Here are five quick facts about the company’s stock:
1. Zacks upgraded HealthSouth to “buy” from a “hold” rating.
2. The new price objective from Zacks is $54.
3. There is a suggested potential upside of 24.11 percent from the stock’s previous close.
4. Mid-day last Friday, HealthSouth traded down 3.78 percent, hitting $43.51.
5. HealthSouth’s market cap is $3.81 billion.
More articles on surgery centers:
ASC M&A, real estate today: 3 key thoughts from Jon Vick
The state of ASC business today—5 key thoughts from Ann Geier
24 staffing statistics for orthopedic surgery centers
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
